|
|
|
41
|
66739
|
CATAFLAM DISPERS 50MG TAB (NVS) DICLOFEN (C)
|
DICLOFENAC POTASSIUM
|
CATAFLAM DISPERS
|
12'S
|
C
|
12.07
|
1.0058
|
TAB
|
15
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
66739
|
CATAFLAM DISPERS 50MG TAB (NVS) DICLOFEN
|
DICLOFENAC POTASSIUM
|
CATAFLAM DISPERS
|
12'S
|
C
|
12.07
|
1.01
|
TAB
|
15
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6673AB
|
CATAFLAM SOFT GEL 50MG CAP (NVS/COL) DICLOFEN
|
DICLOFENAC POTASSIUM
|
CATAFLAM SOFT GEL
|
50'S
|
C
|
46.81
|
0.94
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6673AB
|
CATAFLAM SOFT GEL 50MG CAP (NVS) DICLOFE (C)
|
DICLOFENAC POTASSIUM
|
CATAFLAM SOFT GEL
|
50'S
|
C
|
46.81
|
0.9362
|
CAP
|
0
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6673AB
|
CATAFLAM SOFT GEL 50MG CAP (NVS) DICLOFE
|
DICLOFENAC POTASSIUM
|
CATAFLAM SOFT GEL
|
50'S
|
C
|
46.81
|
0.94
|
CAP
|
0
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6673AE
|
DICLO-K 50MG TAB (RYV/ALW) DICLOFENAC POTASSI
|
DICLOFENAC POTASSIUM
|
DICLO-K
|
100'S
|
A
|
2.69
|
0.03
|
TABLET
|
15
|
TAB
|
RYV
|
RYVIS PHARMA PVT. LTD
|
ALW
|
ALTIMAR WHOLESALERS INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6673AE
|
DICLO-K 50MG TAB (RYV) DICLOFENAC POTASS
|
DICLOFENAC POTASSIUM
|
DICLO-K
|
100'S
|
A
|
4.05
|
0.0405
|
TAB
|
15
|
BOX
|
RYV
|
RYVIS PHARMA PVT. LTD
|
ALW
|
ALTIMAR WHOLESALERS INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
6673AN
|
DICLOFENAC POTASSIUM 50MG TAB (HEA)
|
DICLOFENAC POTASSIUM
|
DICLOFENAC POTASSIUM
|
2X10
|
A
|
1.41
|
0.0707
|
TAB
|
15
|
BOX
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
6673AP
|
DICLOFENAC POTASSIUM 50MG TAB (MCP)
|
DICLOFENAC POTASSIUM
|
DICLOFENAC
|
10X10
|
A
|
3.48
|
0.0348
|
TAB
|
15
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6673AT
|
DICLOFENAC POTASSIUM 50MG TAB (ZYP)
|
DICLOFENAC POTASSIUM
|
DICLOFENAC POTASSIUM
|
10X10
|
A
|
2.94
|
0.03
|
TAB
|
15
|
BLIS
|
ZYP
|
ZYPHAR'S PHARMACEUTICAL Pvt Ltd
|
RXP
|
RX PRO INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6673AY
|
DICLOFENAC POTASSIUM 50MG TAB (HEA)
|
DICLOFENAC POTASSIUM
|
DICLOFENAC POTASSIUM
|
2X10
|
C
|
1.33
|
0.07
|
TAB
|
15
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2025-10-31
|
|
|
|
42
|
6673AZ
|
DICLOFENAC POTASSIUM 50MG TAB (HEA)
|
DICLOFENAC POTASSIUM
|
DICLOFENAC
|
2X10
|
C
|
1.33
|
0.07
|
TAB
|
15
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-01-26
|
|
|
|
42
|
6673BA
|
DICLOFENAC POTASSIUM 50MG TAB (HEA) ©
|
DICLOFENAC POTASSIUM
|
DICLOFENAC POTASSIUM
|
2X10
|
C
|
1.33
|
0.07
|
TAB
|
15
|
|
HEA
|
HEALTH 2000 INC
|
STO
|
BRYDEN STOKES LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-02-27
|
|
|
|
42
|
6673BB
|
DICLOFENAC POTASSIUM 50MG TAB (FSB)
|
DICLOFENAC POTASSIUM
|
DICLOFENAC POTASSIUM
|
10X10
|
A
|
2.75
|
0.03
|
TAB
|
15
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-03-05
|
|
|
|
40
|
6673H
|
CATAFLAM 50MG TAB (NVS/COL) DICLOFENAC POTASS
|
DICLOFENAC POTASSIUM
|
CATAFLAM
|
50'S
|
C
|
46.81
|
0.94
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6673H
|
CATAFLAM 50MG TAB (NVS) DICLOFENAC POTAS (C)
|
DICLOFENAC POTASSIUM
|
CATAFLAM
|
50'S
|
C
|
46.81
|
0.9362
|
TAB
|
15
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6673H
|
CATAFLAM 50MG TAB (NVS) DICLOFENAC POTAS
|
DICLOFENAC POTASSIUM
|
CATAFLAM
|
50'S
|
C
|
46.81
|
0.94
|
TAB
|
15
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
66742
|
LAFENAC 25MG/ML INJ (LDP/AHI) DICLOFENAC POTASSIUM
|
DICLOFENAC POTASSIUM
|
LAFENAC
|
10X3ML
|
B
|
45.34
|
4.53
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
66746
|
DICLOFENAC POTASSIUM 25MG/ML INJ (KWA)
|
DICLOFENAC POTASSIUM
|
DICLOFENAC POTASSIUM
|
3ML VIAL
|
B
|
1.8756
|
1.8756
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
IM
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6691AD
|
QLAIRA TAB (BSP/COL) ESTRADIOL/DIENOGEST
|
DIENOGEST|ESTRADIOL
|
QLAIRA
|
28'S
|
C
|
27.18
|
0.97
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|